Status:
COMPLETED
Evaluation of the Efficacy and Safety of Zinc in Viral Infections
Lead Sponsor:
University of Monastir
Conditions:
SARS-CoV2 Infection
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The main objective of the clinical study is to evaluate the efficacy of Zinc supplementation in non-critically ill Covid-19 patients..
Detailed Description
The VIZIR study is a national, longitudinal, multi-centre study conducted over a 3-month follow-up period. The priori hypothesis was that supplementation with zinc would reduce 30-day mortality and n...
Eligibility Criteria
Inclusion
- Age 18 years and over .
- Sars-Cov2 infection Diagnosed with RT PCR , Rapid Test or Chest CT-Scan performed within the less than 5 days of symptoms.
Exclusion
- Patients who received zinc before the start of the protocol.
- heart, liver, malignancies, or renal failure (estimated glomerular filtration rate ≤30 mL/min/1.73 m2);
- Mental disorders .
- Chronic Dialysis.
- Hospitalisation in ICU (use of respiratory or cardiovascular organ support (oxygen delivered by high-flow nasal cannula, noninvasive or invasive mechanical ventilation, or the use of vasopressors or inotropes). .
- Known hypersensitivity to zinc.
- unsuitability for oral administration
Key Trial Info
Start Date :
February 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2022
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT05212480
Start Date
February 15 2022
End Date
May 4 2022
Last Update
March 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
EPS Fattouma Bourguiba Monastir
Monastir, Tunisia, 5000